Agape ATP Corp income statement
In fiscal 2025, Agape ATP Corp reported revenue of $1.5m, up 15.2% on the year before, operating income of −$3.3m (a -213.7% margin) and net income of −$2.3m, or −$2.85 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2018Jun 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 487 | 1,290 | 3,453 | 1,017 | 1,857 | 1,431 | 1,323 | 1,524 | 1,152 |
| Cost of revenue | 441 | 1,201 | 776 | 297 | 666 | 495 | 564 | 686 | 413 |
| Gross profit | 46 | 89 | 2,677 | 720 | 1,191 | 937 | 759 | 838 | 644 |
| Selling, general and administrative | 280 | — | — | — | — | — | — | — | — |
| General and administrative | — | 396 | 1,628 | 1,746 | 1,957 | 2,366 | 3,135 | 3,779 | 3,530 |
| Operating income | −234 | −315 | −158 | −1,859 | −1,533 | −2,147 | −2,573 | −3,257 | −3,128 |
| Income before tax | −125 | −723 | 516 | −2,388 | −1,670 | −2,106 | −2,481 | −2,305 | −1,226 |
| Income tax | 5 | −7 | 162 | 137 | −4 | 4 | 5 | 2 | — |
| Net income | −130 | −716 | 355 | −2,524 | −1,687 | −2,102 | −2,470 | −2,280 | −1,155 |
| Diluted EPS | $0.00 | $0.00 | $0.00 | −$0.00 | −$0.00 | −$2.75 | −$3.17 | −$2.85 | — |
| Diluted shares (average) | 3,730m | 3,763m | 3,764m | 3,762m | 878m | 758m | — | — | — |
| EBITDA | — | — | −157 | −1,783 | −1,462 | −2,076 | −2,521 | −3,236 | −3,122 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 331 | 360 | 289 | 465 | 371 | 399 | 274 | 109 |
| Cost of revenue | 147 | 182 | 133 | 142 | 131 | 165 | 114 | 2 |
| Gross profit | 184 | 178 | 156 | 65 | 239 | 234 | 159 | 12 |
| General and administrative | 684 | 982 | 806 | 611 | 751 | 1,455 | 795 | 529 |
| Operating income | −548 | −848 | −720 | −622 | −601 | −1,298 | −677 | −551 |
| Income before tax | −527 | −835 | −713 | −608 | −594 | −375 | −341 | 84 |
| Income tax | −3 | −9 | — | — | 1 | 1 | — | — |
| Net income | −510 | −808 | −713 | −623 | −587 | −377 | −341 | 149 |
| Diluted EPS | −$1.30 | −$6.26 | −$0.73 | −$0.62 | −$0.50 | −$2.80 | −$0.33 | $0.15 |
| EBITDA | −541 | −828 | −708 | −618 | −599 | −1,296 | −676 | −550 |
Compare with peers
- Mangoceuticals, Inc. income statement
- Akso Health Group income statement
- American Shared Hospital Services income statement
- Cryo Cell International Inc income statement
- Haoxi Health Technology Ltd income statement
Head to head: ATPC vs MGRXAHG vs ATPCAMS vs ATPC
More: Health Care Services stocks compared, Health Care sector, rankings of US companies